Business
Turbett Surgical Appoints Kevin Danahy as President and Chief Executive Officer to Lead Growth Phase
ROCHESTER, N.Y., May 06, 2026--Turbett Surgical is proud to announce the appointment of Kevin Danahy as President and Chief Executive Officer. A visionary leader known for his "founder-mentality," Danahy joins the company with a mandate to instill a high-performance culture and lead the organization through its next era of clinical expansion and commercial excellence.
About this update from Pulse Biosciences, Inc
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":206,"url":"https://media.zenfs.com/en/business-wire.com/d55354bad91b484e191c5ab811030594"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/fmWirA4NJtVW5qzMkoZAFw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQxMg--/https://media.zenfs.com/en/business-wire.com/d55354bad91b484e191c5ab811030594","width":480,"height":206},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/Jt7zc2H1xP1f5Vwzbkr1MA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTI3NQ--/https://media.zenfs.com/en/business-wire.com/d55354bad91b484e191c5ab811030594","width":480,"height":206}},"lazy":false},{"type":"text","content":"ROCHESTER, N.Y., May 06, 2026--(BUSINESS WIRE)--Turbett Surgical is proud to announce the appointment of Kevin Danahy as President and Chief Executive Officer. A visionary leader known for his "founder-mentality," Danahy joins the company with a mandate to instill a high-performance culture and lead the organization through its next era of clinical expansion and commercial excellence.","length":397,"tagName":"p"},{"type":"text","content":"Danahy most recently served at Pulse Biosciences in key executive roles, including President and CEO, during the company's critical stage of transition to a cardiac and oncology focus. Previously, he was President and CEO of private equity-backed Solmetex, where he successfully rebuilt the executive leadership team and accelerated the company to a successful exit. In addition to his leadership success at both Pulse and Solmetex, Kevin developed the foundation of his leadership skills over two decades of leadership positions at several of the world’s most respected medical device companies, including Zimmer Biomet, Intuitive Surgical, and Medtronic.","length":660,"tagName":"p"},{"type":"text","content":""Kevin brings a track record of building high growth, customer-focused organizations to Turbett and we believe that his experience will enhance their mission of expanding the US and international reach of this innovative product," said Joe Siletto, Co-Managing Partner of J.P. Morgan Life Sciences Private Capital and Chairman of the Board at Turbett. "Kevin has proven his ability to build teams while focusing on customer needs and patient outcomes, and we are ...